MARATTO

article · Kidney International Reports

WCN26-4701 CLINICAL PROFILE AND TREATMENT OUTCOMES OF THERAPEUTIC APHERESIS FOR RECURRENT FOCAL SEGMENTAL GLOMERULOSCLEROSIS AFTER KIDNEY TRANSPLANTATION

Abstract

strategies are essential to sustain this progress and achieve parity.Realworld national data from GODT and NOTTO offer a reliable foundation for policy monitoring and global benchmarking.I have no potential conflict of interest to disclose.I did not use generative AI and AI-assisted technologies in the writing process.

Research topics

  • Kidney Stones and Urolithiasis Treatments
  • Chronic Kidney Disease and Diabetes
  • Renal and Vascular Pathologies

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1016/j.ekir.2026.105484

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.